@article{articlef794ea55,
title   = {Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study},
author = {Swain, Sandra M. and Miles, David and Kim, Sung Bae and Im, Young-Hyuck and Im, Seock-Ah and Semiglazov, Vladimir and Ciruelos, Eva M. and Schneeweiss, Andreas and Loi, Sherene and Monturus, Estefanía and Clark, Emma and Knott, Adam and Restuccia, Eleonora and Benyunes, Mark C. and Cortés, Javier and Andrade, Jurandyr Moreira de},
year = {2020},
doi = {10.1016/S1470-2045(19)30863-0},
journal   = {The Lancet Oncology}
}